About Sunbird Bio
Sunbird Bio is a biotechnology company developing proprietary blood-based diagnostic tests to improve the diagnosis and treatment of neurological disorders (including Alzheimer's and Parkinson's disease) and early-stage cancer. Its flagship APEX platform detects and differentiates disease-specific aggregated proteins directly from a blood draw, enabling earlier and more accurate diagnoses. The company serves biopharma researchers and clinicians seeking non-invasive diagnostic solutions for neurodegenerative diseases.
Company details
Funding
Total raised
$14M
Last stage
Series B
Investors
Founders
Carine Lim
Ph.D. from National University of Singapore (Shao Lab). Co-founded Sunbird Bio and leads product development.
LinkedIn
Huilin Shao
Ph.D. in Biophysics from Harvard University. Distinguished presidential professor at the National University of Singapore. Founded Sunbird Bio on technologies originating from her laboratory.
LinkedInNicholas Ho
Ph.D. in Computational and Systems Biology from Washington University in St. Louis. Previously a senior research fellow at Shao Lab, NUS. Referred to as scientific co-founder and head of innovation at Sunbird Bio.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.